-+ 0.00%
-+ 0.00%
-+ 0.00%

UPDATE: Puma Biotechnology Sees FY2026 Sales $214.000M-$221.000M vs $220.000M Est

Benzinga·02/26/2026 23:58:35
Listen to the news
Puma Biotechnology (NASDAQ:PBYI) sees FY2026 sales of $214.000 million-$221.000 million vs $220.000 million analyst estimate.